Celldex Therapeutics reported $648.44M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celldex Therapeutics USD 648.44M 43.97M Sep/2025
Glaxosmithkline GBP 82.45B 23.19B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025